Source:http://linkedlifedata.com/resource/pubmed/id/12943657
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-8-28
|
pubmed:abstractText |
Useful biomarkers are needed for early detection of cancers. To demonstrate the potential diagnostic usefulness of a new proteomic technology, we performed Expression Difference Mapping analysis on 39 cancer cell lines from 9 different tissues using ProteinChip technology. A protein biomarker candidate of 12kDa was found in colon cancer cells. We then optimized the purification conditions for this biomarker by utilizing Retentate Chromatography mass spectrometry (RC-MS). The optimized purification conditions developed "on-chip" were directly transferred to conventional chromatography to purify the biomarker, which was identified as prothymosin-alpha by ProteinChip time-of-flight mass spectrometry (TOF MS) and ProteinChip-Tandem MS systems. The relative expression level of prothymosin-alpha between colon cancer cells and normal colon mucosal cells was evaluated on the same ProteinChip platform. Prothymosin-alpha expression in colon cancer cells was clearly higher than in normal colon cells. These results indicate that prothymosin-alpha could be a potential biomarker for colon cancer, and that the ProteinChip platform could perform the whole process of biomarker discovery from screening to evaluation of the identified marker.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors,
http://linkedlifedata.com/resource/pubmed/chemical/Thymosin,
http://linkedlifedata.com/resource/pubmed/chemical/Trypsin,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/prothymosin alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-291X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
309
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
18-25
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12943657-Colon,
pubmed-meshheading:12943657-Dose-Response Relationship, Drug,
pubmed-meshheading:12943657-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:12943657-Humans,
pubmed-meshheading:12943657-Mass Spectrometry,
pubmed-meshheading:12943657-Protein Array Analysis,
pubmed-meshheading:12943657-Protein Precursors,
pubmed-meshheading:12943657-Thymosin,
pubmed-meshheading:12943657-Trypsin,
pubmed-meshheading:12943657-Tumor Cells, Cultured,
pubmed-meshheading:12943657-Tumor Markers, Biological
|
pubmed:year |
2003
|
pubmed:articleTitle |
Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform.
|
pubmed:affiliation |
Yokohama Laboratory, Ciphergen Biosystems K.K., Yokohama Business Park East Tower 14F, 134 Godo-cho, Hodogaya-ku, Yokohama, Kanagawa, Japan.
|
pubmed:publicationType |
Journal Article
|